Industry giants like Takeda Pharmaceuticals, Pfizer, Novartis, and Bayer are revolutionizing treatment landscapes, paving the way for enhanced patien ...

Excessive screen time and chronic stress, especially in young people, disrupt circadian rhythms and immune function, ...

Addison’s disease is a rare autoimmune disorder where the adrenal glands don’t produce enough vital hormones, causing fatigue ...

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

and most severe side effects being adrenal insufficiency. The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic colorectal cancer.

Delta-Radiomics Using Machine Learning Classifiers With Auxiliary Data Sets to Predict Disease Progression During Magnetic Resonance-Guided Radiotherapy in Adrenal Metastases This study was approved ...

Adrenal tumors are a heterogeneous group of tumors characterized ... and to identify predictors of recurrence (local recurrence and/or metastatic disease). This retrospective multicenter study ...

The FDA accepts and grants priority review to Merck's sNDA for Welireg to treat advanced pheochromocytoma and paraganglioma. A decision is due on May 26, 2025.

The obligatory adrenal insufficiency caused by surgery ... Mitotane should be started in patients with metastatic disease or a lack of surgical options, whether the tumor is functioning or not.

The adrenal gland was completely replaced by tumor ... carcinoma as the stimulus for the widespread osteoblastic metastases is in itself unusual. No such cases were found in the x-ray files ...

The FDA has accepted Merck's (NYSE:MRK) supplemental New Drug Application with priority review for its drug Welireg, also known as belzutifan, for the treatment of a rare type of adrenal gland tumors.